Loading...
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
Lung cancer is one of the deadliest and most common malignancies in the world, representing one of the greatest challenges in cancer treatment. Immunotherapy is rapidly changing standard treatment schedule and outcomes for patients with advanced malignancies. However, several ongoing studies are sti...
Saved in:
| Published in: | Mediators Inflamm |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Hindawi
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885300/ https://ncbi.nlm.nih.gov/pubmed/31827379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7652014 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|